Table 1 Patients' clinical and preclinical characteristics
Clinical characteristics | Number of patients | Percentage |
|---|---|---|
Gender | Â | Â |
Male | 297 | 85.30% |
Female | 51 | 14.70% |
Age: 62.2 ± 9 (43-82 years) |  |  |
41-55 | 83 | 23.90% |
56-65 | 136 | 39.05% |
> 65 | 129 | 37.05% |
Diabetes | 49 | 14.10% |
History AF (<3 months) | 48 | 13.80% |
History MI | 131 | 37.70% |
Anterior MI | 89 | 25.60% |
Posterior MI | 42 | 12.10% |
COPD | 44 | 12.60% |
OPA | 48 | 13.80% |
Unstable angina | 30 | 8.60% |
Obesity (BMI > 30) | 43 | 12.40% |
Hypertension | 151 | 43.40% |
Preclinical characteristics | Â | Â |
Diseased vessels | Â | Â |
CAD-1 | 19 | 5.50% |
CAD-2 | 56 | 16.10% |
CAD-3 | 270 | 77.60% |
LMCAD | 34 | 9.80% |
E.F | Â | Â |
0.30-0.40 | 53 | 15.20% |
0.40-0.55 | 64 | 18.40% |
> 0.55 | 231 | 66.40% |
Mild MR | 22 | 6.30% |
L.A dilation (> 40 mm) | 26 | 7.50% |
Proximal stenosis | Â | Â |
Proximal LAD | 81 | 23.30% |
Proximal LCx | 114 | 32.80% |
Proximal RCA | 74 | 21.30% |
Dyslipidemia | 189 | 54.30% |
Medical treatment | Â | Â |
Nitrates | 296 | 85.10% |
b-blockers | 258 | 74.10% |
Ca++blockers | 143 | 41.10% |
Anti-platelets | 284 | 81.60% |